RxDoctor Payments Data

David Webber, DO

Family Medicine · Helena, ARNPI 1760472021

Payments from drug & device makers

$424in general payments, 2019–2025

Across 13 payments — averaging $32.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ancora Heart, Inc.$236
  • Lilly USA, LLC$51
  • AbbVie$34
  • Merck$28
  • Johnson & Johnson$24
  • Abbott$20
  • plus $30 from 2 others

What the payments were for

  • Food & beverage$424100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$424 in reported general payments places this provider in the 45th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$82,875
Medicare patients
232
Services billed
1,536

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate89$79,535
LinzessLinaclotide57$48,895
JardianceEmpagliflozin42$41,401
EliquisApixaban35$29,492
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen905$29,045
TradjentaLinagliptin39$27,219
FarxigaDapagliflozin Propanediol33$25,678
OzempicSemaglutide21$20,037
XareltoRivaroxaban32$16,435
JanumetSitagliptin Phos/Metformin Hcl25$15,857
MyrbetriqMirabegron24$13,553
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,902
Combivent RespimatIpratropium/Albuterol Sulfate18$8,749
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,064
Omeprazole368$6,688

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$28$95,393114 claims
AbbVieLinzess$34$48,89557 claims
AstraZenecaFarxiga, Symbicort$15$31,04751 claims
Johnson & JohnsonXarelto$24$16,43532 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Helena

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →